224 related articles for article (PubMed ID: 15998660)
1. Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production.
Carey PE; Gerrard J; Cline GW; Dalla Man C; English PT; Firbank MJ; Cobelli C; Taylor R
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E941-7. PubMed ID: 15998660
[TBL] [Abstract][Full Text] [Related]
2. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
Carpentier AC; Frisch F; Cyr D; Généreux P; Patterson BW; Giguère R; Baillargeon JP
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273
[TBL] [Abstract][Full Text] [Related]
3. The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans.
Rigazio S; Lehto HR; Tuunanen H; Någren K; Kankaanpaa M; Simi C; Borra R; Naum AG; Parkkola R; Knuuti J; Nuutila P; Iozzo P
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E413-9. PubMed ID: 18505832
[TBL] [Abstract][Full Text] [Related]
4. Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients.
Gastaldelli A; Casolaro A; Ciociaro D; Frascerra S; Nannipieri M; Buzzigoli E; Ferrannini E
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E225-30. PubMed ID: 19417125
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
6. Lipid-dependent control of hepatic glycogen stores in healthy humans.
Stingl H; Krssák M; Krebs M; Bischof MG; Nowotny P; Fürnsinn C; Shulman GI; Waldhäusl W; Roden M
Diabetologia; 2001 Jan; 44(1):48-54. PubMed ID: 11206411
[TBL] [Abstract][Full Text] [Related]
7. Regulation of endogenous glucose production after a mixed meal in type 2 diabetes.
Singhal P; Caumo A; Carey PE; Cobelli C; Taylor R
Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E275-83. PubMed ID: 12110532
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
Toft I; Jenssen T
Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
[TBL] [Abstract][Full Text] [Related]
9. Plasma adiponectin is modestly decreased during 24-hour insulin infusion but not after inhibition of lipolysis by Acipimox.
Dullaart RP; Riemens SC; Meinardi JR; Wolffenbuttel BH; Sluiter WJ
Scand J Clin Lab Invest; 2005; 65(6):523-31. PubMed ID: 16179286
[TBL] [Abstract][Full Text] [Related]
10. Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin.
Jazet IM; Pijl H; Frölich M; Romijn JA; Meinders AE
Metabolism; 2005 Jun; 54(6):705-12. PubMed ID: 15931603
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the postprandial phase by beta-glucan in overweight subjects: effects on glucose and insulin kinetics.
Nazare JA; Normand S; Oste Triantafyllou A; Brac de la Perrière A; Desage M; Laville M
Mol Nutr Food Res; 2009 Mar; 53(3):361-9. PubMed ID: 18837470
[TBL] [Abstract][Full Text] [Related]
12. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes.
Ravikumar B; Carey PE; Snaar JE; Deelchand DK; Cook DB; Neely RD; English PT; Firbank MJ; Morris PG; Taylor R
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E789-97. PubMed ID: 15572652
[TBL] [Abstract][Full Text] [Related]
13. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.
Lam TK; van de Werve G; Giacca A
Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E281-90. PubMed ID: 12531742
[TBL] [Abstract][Full Text] [Related]
14. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content.
Ravikumar B; Gerrard J; Dalla Man C; Firbank MJ; Lane A; English PT; Cobelli C; Taylor R
Diabetes; 2008 Sep; 57(9):2288-95. PubMed ID: 18535187
[TBL] [Abstract][Full Text] [Related]
16. Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles.
Vella A; Reed AS; Charkoudian N; Shah P; Basu R; Basu A; Joyner MJ; Rizza RA
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E25-30. PubMed ID: 12637258
[TBL] [Abstract][Full Text] [Related]
17. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta.
Lam TK; Yoshii H; Haber CA; Bogdanovic E; Lam L; Fantus IG; Giacca A
Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E682-91. PubMed ID: 12217885
[TBL] [Abstract][Full Text] [Related]
18. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
Boden G; Cheung P; Stein TP; Kresge K; Mozzoli M
Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E12-9. PubMed ID: 12067837
[TBL] [Abstract][Full Text] [Related]
19. Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects.
Carey PE; Halliday J; Snaar JE; Morris PG; Taylor R
Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E688-94. PubMed ID: 12453829
[TBL] [Abstract][Full Text] [Related]
20. High-fat diet elevates resting intramuscular triglyceride concentration and whole body lipolysis during exercise.
Zderic TW; Davidson CJ; Schenk S; Byerley LO; Coyle EF
Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E217-25. PubMed ID: 14559721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
